Scientists have created a detailed map of gene activity in the brain's prefrontal cortex, offering new insights into both normal brain development and major neurological and psychiatric conditions like Alzheimer's, Parkinson's, and schizophrenia. The prefrontal cortex, located behind the forehead, is essential for decision-making, emotional control, planning, and adapting behavior. It is especially sensitive to aging and often affected in various brain disorders. The study analyzed gene activity in the nuclei of over 6.3 million brain cells, including neurons, immune cells, blood vessels, and support cells, using tissue samples from 1,494 donors ranging in age from infancy to 108 years. The donors represented a variety of genetic backgrounds and included individuals with and without diagnosed brain conditions such as schizophrenia, bipolar disorder, and various types of dementia. This comprehensive approach allowed researchers to compare gene activity across different ages and conditions. The research identified both common molecular patterns across several diseases and unique signatures specific to individual disorders. Dr. Panos Roussos, who led the study at the Icahn School of Medicine at Mount Sinai, explained that these findings help researchers pinpoint where disease-related changes occur and which biological processes are most relevant. "This map can help identify vulnerable cell populations, reveal processes linked to preserved brain function, and guide the selection of potential treatment targets," he said. The study, conducted through the PsychAD research consortium and funded by the National Institute on Aging, found strong similarities in gene activity related to nerve-cell development, communication, and blood-vessel biology across Alzheimer's, Parkinson's, and other dementias. Shared pathways were also found in microglia, the brain's immune cells, between Alzheimer's and Parkinson's. The research also showed that brain cell activity changed significantly during early development and adulthood, then remained relatively stable during midlife, with changes resuming later in life, especially in support and immune cells. Researchers also identified cellular patterns linked to differences in cognitive ability and depression in Alzheimer's patients. Those who maintained cognitive health despite severe Alzheimer's pathology showed differences in energy-related cellular processes, suggesting potential protective mechanisms. The team also mapped genetic risks for various disorders to specific genes and cell types, examining activity in over 14,000 genes. By analyzing brain tissue from donors who died at different times of day, researchers reconstructed 24-hour cycles of gene activity. These daily patterns were stronger and more synchronized in younger and middle-aged adults than in older adults, suggesting that aging affects how daily biological rhythms are organized in the brain. Finally, the scientists created individual molecular profiles for people with Alzheimer's, uncovering variations in gene regulation and interactions between cell types. These findings help explain why people with the same diagnosis can have different biological profiles and lay the groundwork for more personalized treatment strategies.